NF2 and meningioma: In the case series reporting the use of bevacizumab in the treatment of acoustic neuromas and meningiomas in NF2 [15, 20], there was an association between changes in apparent diffusion coefficient values in MRI and responses, suggesting that this agent was producing its effect via reduction in overall edema and vascular permeability [15].